Company: MAGH
Filing Date: 2025-06-10
Form Type: F-1/A
Source: 0001641172-25-014489
Chunk: 299

Company: Magnitude International Ltd
Filing Date: 2025-06-10
Form: F-1/A
Chunk 299
---
 Resale Shareholders until our Ordinary Shares are listed or quoted on an established public trading market. Thereafter, any sales will occur at prevailing market prices or in privately negotiated prices. The distribution of securities offered hereby may be effected in one or more transactions that may take place in ordinary brokers’ transactions, privately negotiated transactions or through sales to one or more dealers for resale of such securities as principals. Usual and customary or specifically negotiated brokerage fees or commissions may be paid by the Resale Shareholders. No sales of the shares covered by this prospectus shall occur until the Ordinary Shares sold in our initial public offering begin trading on the Nasdaq Capital Market.

On [●], 2025, a registration statement under the Securities Act with respect to our initial public offering of Ordinary Shares was declared effective by the Securities and Exchange Commission. We received approximately US$[●] million in net proceeds from our initial public offering after payment of underwriting discounts and commissions. We did not receive any proceeds from the sale of the Ordinary Shares in our initial public offering by the selling shareholder.

Concurrent with our initial public offering, our Ordinary Shares were listed on the Nasdaq Capital Market under the symbol “MAGH”.

We are an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, and

we have elected to comply with certain reduced public company reporting requirements.

An investment in our Ordinary Shares involves significant risks. You should carefully consider the risk factors beginning on page 9 of this prospectus before you make your decision to invest in our Ordinary Shares.

Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these securities or passed upon the accuracy or adequacy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is [●], 2025</div>

| Alt-1 |

<div align='center'>RESALE PROSPECTUS ALTERNATE PAGE

TABLE OF CONTENTS</div>

|                                                                          | Page  |
| Prospectus                                                               
 Summary                                                                  |       |
| The Offering                                                             | Alt-3 |
| Risk                                                                     
 Factors                                                                  |       |
| Special                                                                  
 Note Regarding Forward-Looking Statements and Industry Data              |       |
| Use                                                                      
 of Proceeds                                                              | Alt-3 |
| Dividend                                                                 
 Policy                                                                   |       |
| Capitalization                                                           |       |
| Dilution                                                                 |       |
| Enforceability                                                           
 of Civil